Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool February 12, 2004 Dave Marino-Nachison	CVS Bags Big 2003 A strong year for the drugstore giant has spilled into January.
The Motley Fool June 10, 2004 Alyce Lomax	Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition.
The Motley Fool March 22, 2004 Alyce Lomax	Walgreen's Green Quarter Investors take an earnings miss to heart. But the future looks good.
The Motley Fool December 23, 2003 Dave Marino-Nachison	Duane Reade's NY Story The well-known New York drugstore chain is going private after just under six years.
The Motley Fool June 2, 2004 Alyce Lomax	Walgreen's Mellow May Will the drugstore chain get a taste of its own medicine?
The Motley Fool July 6, 2004 Alyce Lomax	Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them.
The Motley Fool May 5, 2004 Mike Cianciolo	CVS Prescribes Growth The soon-to-be leader of the drugstore market had a spectacular first quarter as a result of improved sales and margins, and CVS doesn't appear to be showing any signs of slowing down either, as the company continues to expand its business in both traditional and creative ways.
The Motley Fool April 5, 2004 Dave Marino-Nachison	Finally, Eckerd Sells J.C. Penney's drugstore operation will be split between CVS and Jean Coutu.
The Motley Fool February 27, 2004 Dave Marino-Nachison	Out in the Kohl's The retailer's sales keep booming, but expenses are pressuring profits.
The Motley Fool March 24, 2004 Dave Marino-Nachison	Eking Out an Eckerd Deal Investors are still waiting for a new leader to be crowned in the U.S. drugstore business.
The Motley Fool August 3, 2004 Rich Duprey	Penney Kicks Drugstore Habit The retailer has completed its sale of Eckerd Drugs to focus on selling clothes. While investors can and should enjoy Penney's current clear-eyed plans, they ought to keep a watchful eye out for any relapse.
The Motley Fool November 10, 2004 Dave Marino-Nachison	Investors Adjusting to Larger CVS The drugstore company's chains have done nothing but rise since the Eckerd buy. Investors have pulled the company's shares steadily upward since the merger closed.
The Motley Fool August 4, 2004 Phil Wohl	CVS's Prescription for Competition The national drugstore chain is looking to take advantage of increased size.
The Motley Fool August 26, 2004 Dave Marino-Nachison	Getting Into Gottschalks A look at West Coast retailer Gottschalks reveals a market-crushing year-to-date run.
The Motley Fool March 9, 2004 Dave Marino-Nachison	California Wilts Grocery Results Kroger and Albertson's report significant strike-related financial impacts.
The Motley Fool March 17, 2004 Dave Marino-Nachison	S&K's Holidays Fray The men's apparel discounter's holidays held back promising full-year results.
The Motley Fool January 5, 2004 Jeff Hwang	Prescriptions Boost Walgreen Earnings and sales bumped by early flu season and improved non-pharmacy sales.
The Motley Fool February 2, 2005 Alyce Lomax	CVS's Shot in the Arm Buying the Eckerd drugstore chain from J.C. Penney was apparently a good move for CVS. It continues to benefit from the purchase, reporting positive earnings and beating analysts' expectations by a penny.
The Motley Fool January 6, 2004 Dave Marino-Nachison	Tweeter Under Pressure The more the electronics retailer is forced to cut prices, the more trouble it will have competing.
The Motley Fool May 18, 2004 Seth Jayson	Perky Days for J.C. Penney This cornerstone of the American mall is outrunning its rivals.
The Motley Fool January 13, 2004 Alyce Lomax	CVS Fever Drug stores benefit from the flu bug, but for how much longer?
The Motley Fool September 24, 2004 Seth Jayson	Kick This Drug Habit Rite Aid offers slow sales and minuscule shareholder rewards.
The Motley Fool June 25, 2004 Steven Mallas	Rite Aid in the Shadows The first quarter for Rite Aid, the pharmaceutical retailer, shows a profit, but is it time to add this stock to your portfolio?
The Motley Fool December 8, 2004 Nathan Slaughter	What's Wrong at Rite-Aid? Rite-Aid steers guidance lower after a difficult November.
The Motley Fool August 17, 2004 Nathan Slaughter	J.C. Penney on the Rise The retailer hits its stride after shedding Eckerd Drugstores.
The Motley Fool March 2, 2004 Dave Marino-Nachison	BJ's Stands Strong The wholesale club isn't lying down in front of bigger competition.
The Motley Fool January 26, 2004 Jason Matthews	A Penney Saved Department store retailer J.C. Penney cuts jobs and restructures.
The Motley Fool July 6, 2004 Steven Mallas	Walgreen's Sunny Sales The retail pharmacy has a resplendently ruddy June, with comp sales increasing more than 10%.
The Motley Fool May 9, 2005 Timothy M. Otte	Flu Means All's Well for CVS Strong comp sales and benefits from the Eckerd acquisition drive CVS to a solid first quarter. Investors, take note.
The Motley Fool February 5, 2004 Dave Marino-Nachison	Aeropostale Flying High The teen apparel retailer managed a same-store sales gain of nearly 18% in January.
The Motley Fool January 8, 2007 Matthew Crews	CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note.
The Motley Fool September 7, 2004 Seth Jayson	Rejecting Rite Aid Shares of the drugstore chain droped 13%, and may prove to be a bargain if this is indeed a temporary slowdown and management can deliver more robust growth.
The Motley Fool February 26, 2004 Alyce Lomax	Pinching J.C. Penney Eckerd is still a pain, but will Penney fly when it's on its own? Penney's reported a net loss of $1.07 billion, or $3.42 per share, as compared to earnings of $202 million, or $0.68 per share, in the same quarter last year.
The Motley Fool February 3, 2006 Nathan Parmelee	CVS Looks Healthy The drugstore chain handles acquisitions without faltering -- this stock may be worth considering.
The Motley Fool June 25, 2007 Ryan Fuhrmann	Foolish Forecast: Rite Aid Aims for Healthy Growth The drugstore operator is set to report its first-quarter earnings. Investors, here is what you can expect to see.
The Motley Fool February 24, 2004 Dave Marino-Nachison	Wild Oats' Organic Growth The upscale grocer is optimistic about 2004 -- but investors are already catching on.
The Motley Fool September 27, 2004 Phil Wohl	Walgreen: Prescription for Success The leading drugstore retailer is leveraging prescription sales to produce record results. Fourth-quarter earnings grew to $0.32 per share, which was an 18% improvement over last year's $0.27.
The Motley Fool March 9, 2004 Alyce Lomax	February Frenzy at CVS, Rite Aid The flu season's early end hasn't stopped drugstore retailers.
The Motley Fool August 15, 2005 Bobby Shethia	Walgreen's Prescription for Success The drugstore chain's smart and steady growth makes it a good choice for investors.
The Motley Fool February 11, 2004 Dave Marino-Nachison	Unwrapping Office Depot The office supply giant is counting on a return to health in 2004.
The Motley Fool July 8, 2004 Alyce Lomax	J.C. Penney Rules June J.C. Penney succeeds in a month when many lower-priced retailers did not.
The Motley Fool June 21, 2004 Seth Jayson	Walgreen's Fine Follow-Up It's another solid quarter for America's soon-to-be No. 2 drugstore.
The Motley Fool September 22, 2006 Ryan Fuhrmann	More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note.
The Motley Fool July 5, 2005 Alyce Lomax	Business As Usual at Walgreen Walgreen's same-store sales for June certainly don't disappoint. Investors might question whether the retail pharmacy can keep up the great work.
The Motley Fool February 3, 2004 Dave Marino-Nachison	Sport Chalet's Winning Mix Same-store sales aren't booming, but the sporting goods retailer is still a competitor.
The Motley Fool March 5, 2004 Dave Marino-Nachison	Ultimate-ly Disappointing Things aren't getting easier for the electronics retailer, which delayed results today.
The Motley Fool January 13, 2004 Dave Marino-Nachison	Borders' Page-Turning Holidays The bookseller's holidays were cheerful.
The Motley Fool February 6, 2004 Bill Mann	Wal-Mart Sales Foretell Danger Americans continue to spend themselves silly. What happens when the bill comes due?
The Motley Fool February 24, 2004 Alyce Lomax	Federated's Fresh Quarter It's been a busy couple of months for the name behind Bloomingdale's and Macy's.
The Motley Fool September 14, 2004 Nathan Slaughter	Grocer Takes a Tumble Labor problems and debt retirement contribute to Kroger's second-quarter slip.